Sheila Rohe
Family · Frederick, MDNPI 1972936516
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.3% of the total across 38 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 15.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $1,217 and has fallen 56.7% since, to $528 in 2025.
Across 38 payments — averaging $70.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$412
- Amgen$229
- Novo Nordisk$210
- AstraZeneca$180
- Teva Pharmaceuticals USA, Inc.$173
- Boehringer Ingelheim$164
- plus $1K from 17 others
What the payments were for
- Food & beverage$2,56996%
- Other$974%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 5 | $412 |
| Amgen | 3 | $229 |
| Novo Nordisk | 3 | $210 |
| AstraZeneca(2 entities) | 2 | $180 |
| Teva Pharmaceuticals USA, Inc. | 2 | $173 |
| Boehringer Ingelheim | 2 | $164 |
| Merz North America, Inc. | 1 | $140 |
| Boston Scientific | 2 | $124 |
| Beigene USA, Inc. | 1 | $102 |
| Baxter Healthcare | 1 | $97 |
| Dexcom, Inc. | 1 | $97 |
| Axsome Therapeutics, Inc. | 1 | $87 |
| Nevro Corp. | 1 | $85 |
| Neurocrine Biosciences, Inc. | 1 | $83 |
| EMD Serono, Inc. | 1 | $80 |
| Bayer | 2 | $79 |
| Coloplast | 1 | $77 |
| Biogen | 1 | $70 |
| Sumitomo Pharma America, Inc. | 1 | $57 |
| Revance Therapeutics, Inc. | 2 | $48 |
| Galderma Laboratories, L.p. | 2 | $34 |
| Exact Sciences | 1 | $21 |
| Corium, LLC | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,667 in reported general payments places this provider in the 85th percentile of 2,843 family providers in Maryland.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ProgesteroneProgesterone, Micronized | 17 | $703 |
Paid to pharmacies, not to this prescriber.
Other family in Frederick
- Teri OneilFrederick$17K
- Sandra RizzoFrederick$10K
- Lindsay BittoFrederick$10K
- Erika HoffmanPotomac$226K
- Caroline MansySalisbury$106K
- Hazel Jones-ParkerBaltimore$96K
- Brittany WilsonBaltimore$88K
- Ariana ChaoLutherville$85K
- Meredith SagalHunt Valley$82K
- Sharon Dudley-BrownBel Air$67K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.